(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoic acid

We are (2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoic acid CAS:154212-61-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoic acid
CAS.NO:154212-61-0
Synonyms:(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoic acid
N-(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl)-L-valine
N-{[(2-Isopropyl-1,3-thiazol-4-yl)methyl](methyl)carbamoyl}-L-valine
N-[2-Isopropylthiazol-4-ylMethyl(Methyl)carbaMoyl]-L-valine
N-[N-methyl-N[[(2-isopropyl-4-thiazolyl)methyl]amino]carbonyl]-L-valine
 
Physical and Chemical Properties:
Density 1.2±0.1 g/cm3
Boiling Point 532.6±40.0 °C at 760 mmHg
Molecular Formula C14H23N3O3S
Molecular Weight 313.416
Flash Point 275.9±27.3 °C
 
Specification:
Appearance:A pale yellow to yellow crystalline powder
Assay by potentiometer:≥97.0%
Chromatographic assay:≥99.0%
Moisture:≤0.5%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Ritonavir(CAS:155213-67-5).

(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoic acid


Related News: In 2004, the National Development and Reform Commission, the former Ministry of Health, and the Ministry of Finance jointly formulated and promulgated the Administrative Measures for the Configuration and Use of Large Medical Equipment. This method uses X-ray electronic computer tomography (CT) devices and medical magnetic resonance imaging equipment, digital subtraction angiography X-ray machines of 800 mA or more as the management products of large-scale medical equipment, Purchase and use need to be reported to the provincial health administrative department for approval before approval. However, in recent years, with the comprehensive coverage of medical insurance, such basic medical facilities are being widely popularized, and the relevant implementation rules have directly linked the number of equipment to the number of doctors. Therefore, as the demand for imaging equipment continues to increase, it will have a greater boosting effect on the upstream contrast agent and its raw material market.2-Aminoisonicotinic acid CAS:13362-28-2 Some experts said that in the research and development of chemical medicine, the possibility of large medicines is getting smaller and smaller, and with the popularization of precision treatment, small medicines (high-efficiency medicines) are being introduced more and more.207679-81-0 The bulk-buy program, which currently covers 25 types of medicines, allows no more than three successful bidders access to China’s public hospitals, where most Chinese people buy their drugs.4-(1-Methyl-5-nitro-1H-benzimidazol-2-yl)butanoic acid CAS:31349-48-1 The bulk-buy program, which currently covers 25 types of medicines, allows no more than three successful bidders access to China’s public hospitals, where most Chinese people buy their drugs.“Inceptua Medicines Access is delighted to be selected as Onconova’s partner for the Pre-approval Access Program for rigosertib.

Related Products
Product Name
4-Bromo-3-fluorobenzonitrile View Details
3-Bromo-5-methylpicolinonitrile View Details
Trimethoxymethane View Details
5-Amino-2,4,6-triiodoisophthalic acid manufacturer 3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine manufacturer 1-chloro-9-iodononane manufacturer N-[3-[[2-Chloro-5-(trifluoromethyl)-4-pyrimidinyl]amino]phenyl]carbamic acid 1,1-dimethylethyl ester manufacturer 3-Chlorotoluene manufacturer